Day One Biopharmaceuticals, Inc. Profile Avatar - Palmy Investing

Day One Biopharmaceuticals, Inc.

Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly …

Biotechnology
US, South San Francisco [HQ]
Value per Employee (VpE) · Surveys · Talents

Employees Analysis

Employee Surveys

Employees Asked: -

No survey available at the moment.

End of DAWN's Analysis
CIK: 1845337 CUSIP: 23954D109 ISIN: US23954D1090 LEI: - UEI: -
Secondary Listings
DAWN has no secondary listings inside our databases.